Faculty Opinions recommendation of A prospective study on osmophobia in migraine versus tension-type headache in a large series of attacks.

2019 ◽  
Author(s):  
Mario Peres
Keyword(s):  
Prospective Study ◽  
Tension Type Headache ◽  
Large Series ◽  
Type Headache ◽  
A Prospective Study

A prospective study on osmophobia in migraine versus tension-type headache in a large series of attacks

Cephalalgia ◽  
2019 ◽  
Vol 40 (4) ◽  
pp. 337-346 ◽  
Author(s):  
Alberto Terrin ◽  
Federico Mainardi ◽  
Carlo Lisotto ◽  
Edoardo Mampreso ◽  
Matteo Fuccaro ◽  
...  
Keyword(s):  
Prospective Study ◽  
Diagnostic Criteria ◽  
Migraine Without Aura ◽  
Tension Type Headache ◽  
Headache Disorders ◽  
Headache Attack ◽  
Accompanying Symptoms ◽  
Type Headache ◽  
A Prospective Study

Background In literature, osmophobia is reported as a specific migrainous symptom with a prevalence of up to 95%. Despite the International Classification of Headache Disorders 2nd edition proposal of including osmophobia among accompanying symptoms, it was no longer mentioned in the ICHD 3rd edition. Methods We conducted a prospective study on 193 patients suffering from migraine without aura, migraine with aura, episodic tension-type headache or a combination of these. After a retrospective interview, each patient was asked to describe in detail osmophobia, when present, in the following four headache attacks. Results In all, 45.7% of migraine without aura attacks were associated with osmophobia, 67.2% of migraineurs reported osmophobia in at least a quarter of the attacks. No episodic tension-type headache attack was associated with osmophobia. It was associated with photophobia or phonophobia in 4.3% of migraine without aura attacks, and it was the only accompanying symptom in 4.7% of migraine without aura attacks. The inclusion of osmophobia in the ICHD-3 diagnostic criteria would enable a 9.0% increased diagnostic sensitivity. Conclusion Osmophobia is a specific clinical marker of migraine, easy to ascertain and able to disentangle the sometimes challenging differential diagnosis between migraine without aura and episodic tension-type headache. We recommend its inclusion among the diagnostic criteria for migraine as it increases sensitivity, showing absolute specificity.

A Prospective Study of the Headache Phase in 32 Migraine with Aura Patients

Cephalalgia ◽  
2002 ◽  
Vol 22 (6) ◽  
pp. 411-415 ◽  
Author(s):  
D Cologno ◽  
P Torelli ◽  
GC Manzoni
Keyword(s):  
Prospective Study ◽  
Clinical Features ◽  
Migraine With Aura ◽  
International Headache Society ◽  
Case Series ◽  
Tension Type Headache ◽  
Pain Location ◽  
Headache Centre ◽  
Type Headache ◽  
A Prospective Study

For an accurate description of the clinical features of the headache phase in migraine with aura (MA) attacks, we thought it useful to conduct a prospective study of consecutively referred MA patients seeking treatment at the Headache Centre of the University of Parma Institute of Neurology. The case series included 32 patients (22 women and 10 men). At the time of the first visit, each patient was given a questionnaire to be filled in at the next MA attack. Six patients (four women and two men) had attacks of migraine aura without headache. Among the remaining 26 patients (18 women and eight men), the duration of the headache phase was < 24 h in 23 (88.5%); pain location was bilateral in 14 (53.8%) and unilateral in 12, but occurring on the opposite side to aura only in one patient; pain intensity was mild or moderate in 13 (50.0%). The headache phase of MA appeared to have clinical features that differed widely from patient to patient and was consistent with the International Headache Society diagnostic criteria for migraine without aura in 26.9% of patients and for tension-type headache (TTH) in 23.1%.

scholarly journals Neuroimaging in Outpatients with Tension Type Headache

2015 ◽  
Vol 4 (2) ◽  
pp. 62-66
Author(s):  
Peyman Petramfar ◽  
Sajad Pishgar
Keyword(s):  
Prospective Study ◽  
Tension Type Headache ◽  
Primary Headaches ◽  
Neurological Exam ◽  
Type Headache ◽  
A Prospective Study ◽  
New Onset

Background: Research into the role of neuroimaging in primary headaches such as tension type headache (TTH) is ongoing. In the present study, we aim to evaluate the ability of neuroimaging to detect potential abnormalities in patients with new onset TTH and normal neurological exam. Materials and Methods: In a prospective study, 294 cases of new onset TTH with normal neurological exam, that had neuroimaging, were selected. Imaging was evaluated for significant abnormalities. The percentage of abnormal findings in imaging was calculated. Results: 64(21.8%) patients had MRI. Of them, 21.8% of MRIs revealed abnormal findings. Meanwhile, from 238 CTs, only 0.4% showed abnormalities. Conclusion: Neuroimaging with current quality does not play an important role in management of patients with new onset TTH and normal neurological exam. [GMJ.2015;4(2):62-66]

Headache in Acute Cerebrovascular Disease: A Prospective Clinical Study in 240 Patients

Cephalalgia ◽  
1994 ◽  
Vol 14 (1) ◽  
pp. 37-40 ◽  
Author(s):  
A Arboix ◽  
J Massons ◽  
M Oliveres ◽  
MP Arribas ◽  
F Titus
Keyword(s):  
Ischemic Stroke ◽  
Hemorrhagic Stroke ◽  
Tension Type Headache ◽  
Prospective Clinical Study ◽  
Lacunar Infarcts ◽  
History Of ◽  
Vertebrobasilar Stroke ◽  
Type Headache ◽  
A Prospective Study ◽  
Headache Patients

To evaluate the clinical features of headache in stroke, a prospective study was carried out in 240 consecutive patients with acute stroke who had intact expressive function. Headache occurred in 38%: 32% of 195 patients with ischemic stroke and 64.5% of 45 patients with hemorrhagic stroke ( p < 0.0001). Headache patients were younger (mean age 62 ± 15 vs 67 ± 11.5 years) than non-headache patients ( p < 0.01). A history of previous vascular or tension-type headache was found in 40.5% of the headache group, but in only 23.5% of the non-headache group ( p < 0.01). In ischemic stroke, headache was observed in 41% of thrombotic infarcts, in 39% of cardioembolic infarcts, in 23% of lacunar infarcts and in 26% of TIA. Headache was significantly more common in thrombotic than lacunar infarcts ( p < 0.05). In hemorrhagic stroke, headache was observed in all subarachnoid hemorrhages and in 58% of intraparenchymal hemorrhages. In ischemic stroke, the mean duration of the headache was 25 ± 28 h and in hemorrhagic stroke 64.5 ± 36.5 h ( p < 0.00001). In ischemic stroke the headache was focal in 74% and mild or moderate in intensity in 74%. In hemorrhagic stroke, it was diffuse in 52% and the pain intensity was incapacitating in 70%. Headache was more common in vertebrobasilar stroke (59%), in comparison with carotid stroke (26%) or stroke of unclear vascular topography (33%) ( p < 0.00001). Fifty-six and a half percent of patients with cortical stroke had headaches, as opposed to only 26.5% of patients with subcortical stroke ( p < 0.005). Ten percent of the patients presented with sentinel headache.

Development of persistent headache following stroke: A 3-year follow-up

Cephalalgia ◽  
2014 ◽  
Vol 35 (5) ◽  
pp. 399-409 ◽  
Author(s):  
Anne P Hansen ◽  
Ninna S Marcussen ◽  
Henriette Klit ◽  
Helge Kasch ◽  
Troels S Jensen ◽  
...  
Keyword(s):  
Impact Test ◽  
Medication Overuse ◽  
Medication Use ◽  
Tension Type Headache ◽  
Type Headache ◽  
A Prospective Study ◽  
Persistent Headache ◽  
Headache Impact ◽  
Clear Description

Background Headache following stroke has been described in previous studies with an incidence of 23%–54%, but a clear description of headache developing after stroke onset is still lacking. The aim of this study was to determine the incidence and characteristics of persistent novel headache after stroke and to describe the use of medication, including dipyridamole. Methods As a follow-up to a prospective study, a standardized questionnaire about characteristics of novel headache and medication use was sent out to surviving patients three years after their stroke. Results The questionnaire was sent to 256 patients and returned by 222, of whom 12% (26/222) of patients reported persistent novel headache. Dipyridamole had no significant influence on the incidence. Stroke-attributed headache according to predefined criteria was reported in 7.2% (16/222) of patients, with tension-type-like headache in 50.0%, migraine-like in 31.3% and medication overuse in 6.25% of patients. More than half of patients experienced moderate to severe pain and had a score of 55 or above on the Headache Impact Test-6 scale. Conclusion Novel headache after stroke affects one in 10 patients and seems to be unrelated to dipyridamole use. Persistent headache attributed to stroke is similar to tension-type headache for half of patients.

Variations in the Course of the Thenar Motor Branch of the Median Nerve

1996 ◽  
Vol 21 (3) ◽  
pp. 344-346 ◽  
Author(s):  
P. J. Hurwitz
Keyword(s):  
Carpal Tunnel Syndrome ◽  
Prospective Study ◽  
Median Nerve ◽  
Carpal Tunnel ◽  
Large Series ◽  
Anomalous Origin ◽  
Motor Branch ◽  
Tunnel Syndrome ◽  
A Prospective Study ◽  
Additional Anomaly

In a prospective study of 80 operations in 61 patients for carpal tunnel syndrome, special attention was given to the course of the thenar motor branch and its variations. An anomalous origin of the branch was found in 21%. Multiple motor branches occurred in 12.5%. Seventeen patients had operations on both hands, but anomalies were often found in one side only. Special attention is drawn to an additional anomaly where the motor branch lies superficially to the retinaculum buried in a hypertrophic preligamentous muscle. If this anomaly is not borne in mind, the nerve can easily be injured during splitting of the flexor retinaculum. We found this variation in 9% of our patients, but it is rarely mentioned in the literature and in many large series it is not described at all.

The Impact of Education on the Diagnostic Accuracy of Tension-Type Headache and Migraine: A Prospective Study

Cephalalgia ◽  
2007 ◽  
Vol 27 (1) ◽  
pp. 41-45 ◽  
Author(s):  
N Karli ◽  
M Zarifoglu ◽  
S Erer ◽  
K Pala ◽  
N Akis
Keyword(s):  
Primary Care ◽  
Diagnostic Accuracy ◽  
Education Programme ◽  
Tension Type Headache ◽  
Proper Treatment ◽  
Face To Face ◽  
Before And After ◽  
Type Headache ◽  
A Prospective Study ◽  
The Impact

General practitioners (GPs) diagnose and treat headache in primary care settings. The objective of this study was to investigate the effect of a 2-day headache education programme for GPs primarily on diagnostic accuracy. The education programme included theoretical lectures and face-to-face patient evaluation with headache specialists. Three GPs evaluated headache patients before and after the programme. Each GP was planned to interview a total of 60 patients (30 before, 30 after the programme). All patients were evaluated by headache specialists following evaluation by the GPs. A total of 189 patients were included in this study. Diagnostic accuracy increased from 56.3% to 81.0% after the headache education programme ( P < 0.001), which also significantly improved the choice of proper treatment ( P = 0.043). The headache education programme for GPs significantly improved diagnostic accuracy in patients with tension-type headache and the choice of proper treatment. Such education programmes can be standardized and given to GPs working in the primary care setting. These programmes can be arranged locally by the universities and might have a favourable impact on the diagnosis and treatment of headache.

Medication Overuse Headache: Rates and Predictors for Relapse in a 4-year Prospective Study

Cephalalgia ◽  
2005 ◽  
Vol 25 (1) ◽  
pp. 12-15 ◽  
Author(s):  
Z Katsarava ◽  
M Muessig ◽  
A Dzagnidze ◽  
G Fritsche ◽  
HC Diener ◽  
...  
Keyword(s):  
Prospective Study ◽  
Medication Overuse ◽  
Medication Overuse Headache ◽  
Primary Headache ◽  
Tension Type Headache ◽  
First Year ◽  
Follow Up Study ◽  
Type Headache

We present a prospective 4-year follow-up study of 96 patients with medication overuse headache following withdrawal. Complete datasets were available from 85 patients (89%) 6 months, from 79 patients (82%) 1 year and from 75 patients (78%) 4 years after withdrawal. Twenty-six patients (31%) relapsed within the first 6 months after withdrawal. The number of relapses increased to 32 (41%) 1 year and to 34 (45%) 4 years after withdrawal. The 4-year relapse rate was lower in migraine than in tension-type headache (32% vs. 91%, P ≤ 0.001) and combination of migraine and tension-type headache (32% vs. 70%, P ≤ 0.027) and also lower in patients overusing triptans than analgesics (21% vs. 71%, P ≤ 0.001). The study suggests that the majority of relapses occur within the first year after withdrawal and that the long-term success of withdrawal depends on the type of primary headache and the type of overused medication.

Sign in / Sign up

Export Citation Format

Share Document